Meditech Spine's Talos devices receive FDA clearance for use with allograft...
Meditech Spine's Talos interbody devices have received FDA clearance for use with allograft comprised of cancellous or corticocancellous bone graft.
View ArticleIlluminOss Medical names Manny Avila CEO: 5 takeaways
IlluminOss Medical named Manny Avila CEO.
View ArticleLDR, NuVasive, Spine Wave & more — 23 key notes
Here are 23 key notes on orthopedic and spine device companies over the past week.
View ArticleNASS awards 2 traveling fellowships, 3 research grants
The North American Spine Society awarded two traveling fellowships and several research grants at the annual meeting this past week.
View ArticleDo spine patient expectations match their surgeons'? 4 key notes
Patients are more optimistic about their surgical outcomes than surgeons, and that gap could create issues in the future.
View ArticleSeaSpine launches interbody device: 5 key notes
SeaSpine launched the Cambria NanoMetalene interbody device.
View Article5 leaders in spine: NASS bestows honors for work to advance the field
The North American Spine Society honored five people with recognition awards at the recent annual meeting in Chicago.
View ArticleFrisco Spine in Texas adds 2 locations in Grapevine and Southlake: 5 points
Frisco Spine added two new locations in Grapevine and Southlake, Texas.
View ArticleIlluminOss Medical partners with Orthovative: 5 points
IlluminOss Medical recently entered into an agreement with Orthovative to distribute the IlluminOss System in Germany.
View ArticleAmendia, Promimic enter into strategic venture: 4 things to know
Amendia has entered into a strategic venture with Promimic.
View ArticleStryker, Ziehm Imaging enter into co-marketing agreement: 4 key notes
Ziehm Imaging and the Navigation Division of Stryker have signed a co-marketing agreement.
View ArticleInVivo's pilot study expands to 10 spinal cord injury patients — 5 key notes
The FDA approved an expansion for the InVivo pilot study for the investigational Neuro-Spinal Scaffold.
View Article5 things to know about the optimal spinal fusion length
A new study presented at the 30th Annual North American Spine Society meeting challenges conventional wisdom about the optimal long posterior cervical spine fusion length.
View ArticleSoft Tissue Regeneration launches L-C Ligament clinical trial — 5 takeaways
New Haven, Conn.-based Soft Tissue Regeneration, developer of resorbable polymer scaffolds for repairing soft tissue injuries, initiated a randomized and controlled clinic study for its L-C-ligament...
View ArticleDr. Sang-Ho Lee awarded Parviz Kambin award for endoscopic spine surgery at...
Sang-Ho Lee, MD, chairman of Wooridul Spine Hospital in Korea, received the Parviz Kambin Award at the North American Spine Society meeting in October, according to Korea IT Times.
View ArticleXtant Medical stock listed on NYSE MKT: 3 key notes
Xtant Medical's common stock has been approved for listing on the NYSE MKT stock exchange.
View ArticleEllipse Technologies files $75M IPO: 4 takeaways
Ellipse Technologies has filed for an initial public offering of up to $75 million.
View ArticleSeaSpine creates general counsel position: 5 things to know
SeaSpine appointed Patrick Keran to general counsel.
View ArticleDoes vancomycin help spinal tumor patients? 5 key notes
A new study published in Spine examines intrawound vancomycin to prevent surgical site infection for patients with spinal tumors and non-spinal tumor patients.
View ArticleDr. Jeffrey Wise honored at NASS meeting for his advocacy work: 5 key notes
Jeffrey Wise, MD, of Blue Ridge Orthopaedic and Spine Center in Warrenton, Va., received the Inaugural NASS Spine Advocacy Award at the NASS meeting in October, according to Fauquier.com.
View Article